These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29978477)

  • 1. MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.
    Liang C; Shi S; Meng Q; Liang D; Hua J; Qin Y; Zhang B; Xu J; Ni Q; Yu X
    Int J Cancer; 2018 Dec; 143(11):2919-2931. PubMed ID: 29978477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
    Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
    Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.
    Zhu Y; Tian J; Peng X; Wang X; Yang N; Ying P; Wang H; Li B; Li Y; Zhang M; Cai Y; Lu Z; Niu S; Li Y; Zhong R; Chang J; Miao X
    Eur J Cancer; 2021 Jul; 151():94-105. PubMed ID: 33975060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
    Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
    Dey S; Kwon JJ; Liu S; Hodge GA; Taleb S; Zimmers TA; Wan J; Kota J
    Mol Cancer Res; 2020 Feb; 18(2):311-323. PubMed ID: 31662451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
    PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.
    Dey S; Liu S; Factora TD; Taleb S; Riverahernandez P; Udari L; Zhong X; Wan J; Kota J
    BMC Cancer; 2020 Jul; 20(1):651. PubMed ID: 32660466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
    Liu L; Xiang J; Chen R; Fu D; Hong D; Hao J; Li Y; Li J; Li S; Mou Y; Mai G; Ni Q; Peng L; Qin R; Qian H; Shao C; Sun B; Sun Y; Tao M; Tian B; Wang H; Wang J; Wang L; Wang W; Wang W; Zhang J; Zhao G; Zhou J; Yu X;
    Int J Oncol; 2016 Mar; 48(3):900-7. PubMed ID: 26718269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
    Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
    Mol Cancer Res; 2017 Feb; 15(2):201-212. PubMed ID: 28108627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
    Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
    Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.
    Sun XJ; Liu BY; Yan S; Jiang TH; Cheng HQ; Jiang HS; Cao Y; Mao AW
    Cell Physiol Biochem; 2015; 37(2):707-18. PubMed ID: 26356262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.